Gilead has reported results for a once-yearly intramuscular injection that show blood concentrations of lenacapavir exceeded ...

Life Insurance Corporation of India (LIC) recorded a 28.29 per cent surge in group yearly renewable premiums and a 7.9 per ...

Phase I trial results show the potential of once-yearly lenacapavir as a long-acting PrEP option for HIV, supporting further ...